ADHD Diagnoses On The Rise Among Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 21, 2025.

By Dennis Thompson HealthDay Reporter

TUESDAY, Jan. 21, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) diagnoses have increased among adults in recent years, while remaining stable among teenagers.

ADHD diagnoses among adults increased by 15% between 2020 and 2023, after declining by nearly 11% from 2016 to 2020, researchers reported in a new study published in the journal Psychiatric Research and Clinical Practice.

At the same time, teen ADHD rates remained stable between 2018 and 2023, following a significant 26% decline between 2016 and 2018.

These trends “are likely due to a complex interplay of various factors,” the research team led by Dr. Erick Messias, chair of psychiatry and behavioral neurosciences at St. Louis University School of Medicine, said.

ADHD is more widely known and is less stigmatizing as a diagnosis, researchers said. There’s also increased access to health care services that could lead to diagnosis.

“As knowledge about ADHD symptoms improves among healthcare providers, parents, and teachers, more cases may be identified and diagnosed,” researchers wrote.

In addition, an expansion of diagnostic guidelines for ADHD might have contributed to the increase.

For the study, researchers reviewed medical records for more than 144,000 patients with the Sisters of Saint Mary health care system, which has locations in Illinois, Missouri, Oklahoma and Wisconsin.

The study represents one of the largest efforts to investigate new ADHD diagnoses among teens and adults before, during and after the COVID-19 pandemic, researchers noted.

Adult ADHD can be more difficult to spot, according to the Cleveland Clinic. Symptoms can include forgetfulness, procrastination, chronic restlessness, lack of follow-through and frequently misplacing items.

“Findings from this study support future investigation in identifying potential modifiable risk factors, ensuring sufficient treatment resources, developing targeted interventions, and addressing diagnostic disparities,” the researchers concluded.

The findings were published Jan. 13.

Sources

  • American Psychiatric Association, news release, Jan. 13, 2025
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords